Hypothesis

Aging‑associated loss of the mitochondrial import receptor Tom70 disrupts the coupling of nuclear‑encoded ETC subunit synthesis with their mitochondrial import, leading to accumulation of orphan subunits that sequester matrix NADH. This NADH trapping lowers the free NAD+/NADH ratio required for optimal Complex I activity and for the NADH‑oxidizing function of nicotinamide nucleotide transhydrogenase (NNT). Consequently, NNT‑derived NADPH production falls, compromising antioxidant defense and increasing ROS, which further destabilizes respiratory supercomplexes. Restoring matrix NADH turnover—e.g., by targeted expression of a mitochondrial NADH oxidase—should rescue NAD+/NADH balance, NNT activity, supercomplex formation, and reduce oxidative stress even when Tom70 levels remain low.

Mechanistic Rationale

• Tom70 serves dual roles: (i) as a receptor that binds precursor proteins for the TIM23 translocon and (ii) as a transcriptional co‑activator that drives expression of nucleus‑encoded ETC genes (ATPβ, NDUFB8, COX I) [Tom70-based transcriptional regulation of mitochondrial biogenesis and aging].
• When Tom70 declines, transcription and import become uncoupled. Nascent polypeptides accumulate in the cytosol or intermembrane space, where they can bind NADH with high affinity (as shown for Complex I subunits that stabilize supercomplexes via NADH binding) [NAD+/NADH redox alterations reconfigure metabolism and rejuvenate senescent human mesenchymal stem cells in vitro].
• Sequestration of NADH reduces the free matrix NADH pool, shifting the NAD+/NADH ratio toward a more oxidized state. This impairs two NADH‑dependent processes:
  1. Complex I catalysis, which requires NADH as electron donor.
  2. NNT activity, which uses matrix NADH to reduce NADP+ to NADPH while pumping protons [Mitochondrial NAD+/NADH Redox State and Diabetic Cardiomyopathy].
• Lower NADPH diminishes glutathione and thioredoxin systems, elevating ROS. ROS further promotes dissociation of respiratory supercomplexes, creating a vicious cycle.
• The NAD+ import transporter SLC25A51 can sustain matrix NAD+ independently of cytosolic shuttles [NAD and Mitochondria: Hidden Mechanisms of Cellular Energy Production], but it does not address the NADH‑sequestration problem.
• Providing an alternative route for NADH oxidation—such as a mitochondrially targeted NADH oxidase (e.g., LbNOX) that converts NADH to NAD+ without producing ROS—should replenish the NAD+ pool, relieve NADH trapping, and allow NNT to function using the regenerated NADH.

Testable Predictions

1. Biochemical: In Tom70‑knockdown or senescent human fibroblasts, matrix free NADH (measured with Peredox or SoNar sensors) will be significantly lower than in controls, despite unchanged total NAD+ levels. Overexpression of mitochondrial LbNOX will restore the NADH/NAD+ ratio to youthful levels.
2. Proteomic: Blue‑native PAGE followed by in‑gel activity assays will show decreased Complex I‑containing supercomplexes in Tom70‑deficient cells; LbNOX expression will rescue supercomplex abundance to ≥80 % of control.
3. Metabolomic: NADPH/NADP+ ratio and reduced glutathione (GSH) levels will decline in Tom70‑low cells and be restored by LbNOX.
4. Functional: ROS production (MitoSOX fluorescence) will be elevated in Tom70‑deficient cells and normalized by LbNOX, without altering Tom70 expression.
5. Genetic epistasis: If the hypothesis is correct, LbNOX rescue will be ineffective when NNT is simultaneously knocked out, confirming that the beneficial effect depends on NNT‑mediated NADPH synthesis.

Falsifiability

• If Tom70 reduction does not alter matrix free NADH levels or orphan subunit NADH binding, the core mechanism is invalidated.
• If LbNOX fails to improve NAD+/NADH ratio, supercomplex assembly, or ROS despite restoring NADH oxidation, the hypothesis that NADH sequestration drives the phenotype is falsified.
• If rescuing NADPH via alternative means (e.g., IDH2 overexpression) does not improve supercomplex stability when Tom70 is low, the link between NNT‑derived NADPH and supercomplex maintenance would be questioned.

By linking import‑transcription coupling, NADH compartmentalization, and NNT‑dependent redox balancing, this hypothesis offers a concrete, experimentally tractable framework to explain why NAD+ precursor supplementation alone cannot reverse age‑related ETC decline and points toward therapies that directly regulate mitochondrial NADH turnover.